---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-020652"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T05:11:30.747468+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Allarity shareholders reject equity plan increase and officer exculpation

## Summary
- Thomas H. Jensen re-elected as Class III director with 1,673,698 for, 265,465 withheld.
- Ratification of Wolf & Company as auditor passed with 6,706,148 votes for.
- Proposal to increase 2021 Plan shares from 717,941 to 3,415,068 failed (928,978 for vs 932,866 against).
- Amendment to limit officer liability (Officer Exculpation) also did not pass (1,359,331 for vs 563,585 against).
- Adjournment proposal approved 4,976,159 for, 1,924,694 against; quorum was 41% of outstanding shares.

## SEC filing metadata
- accession: 0001437749-25-020652
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020652/0001437749-25-020652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020652/allr20250617_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-020652
- JSON: https://secwatch.observer/filing/0001437749-25-020652.json
- Plain text: https://secwatch.observer/filing/0001437749-25-020652.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.